Forest Laboratories, Inc. today announced the launch of the STRIDE patient support program to help those prescribed TudorzaA PressairA or DalirespA by answering questions they may have about their chronic obstructive pulmonary disease treatment.
http://ift.tt/1gwnenV
http://ift.tt/1gwnenV
No comments:
Post a Comment